Skip to main content
. 2017 Jan 20;11(2):208–219. doi: 10.1002/1878-0261.12023

Figure 1.

Figure 1

(A) Bar chart showing the average plasma DNA‐mutant fractions detected in ctDNA of patients with newly diagnosed compared to recurrent disease as well as the overall cohort of patients with RAS mutations detected in the plasma by BEAMing. (B) Average value and standard error for all patients (stage III and stage IV), those with newly diagnosed and recurrent disease are 6.82 ± 1.73, 9.11 ± 2.36, and 1.49 ± 0.67, respectively. P = 0.004 for MAF% in newly diagnosed patients compared to those with recurrent disease. P values were derived from a Welch's unequal variances t‐test.